Kyorin pact another arrow in Daiichi Sankyo's South American quiver
09 November 2011
Ian Haydock
Please Login to read the full article.
09 November 2011
Ian Haydock
ian.haydock@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- US and EU filings for Astellas' first-in-class OAB drug mirabegron
- Preliminary Japanese nod moves mirabegron closer to first market
- Transdermal oxybutynin moves towards Japanese filing for overactive bladder
- Sceptical US FDA panel gives nod for Astellas overactive bladder drug
ANALYSIS
Other Informa Analysis
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
